BrightSpring Health Services, Inc. (BTSG)

NASDAQ: BTSG · USD

$59.5

+1.11 (+1.9%)· Recorded snapshot

Market cap	12.4B
Revenue (ttm)	14.4B
Net income (ttm)	366M
EPS (ttm)	$1.64
Shares out	208.3M
P/E (trailing)	36.3x
P/E (forward)	28.8x
Volume	1,535,955
Beta	1.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14.4B
Net income (ttm): 366M
EPS (ttm): $1.64
P/E (trailing): 36.3x
P/E (forward): 28.8x
Market cap: 12.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.8

P25 n/aP50 n/aP75 n/a

Trailing P/E36.3

P25 n/aP50 n/aP75 n/a

ROE13

P25 n/aP50 n/aP75 n/a

ROIC10.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BTSG indicators

Market & fundamental data

Available fields

247

Groups with data

Currency

USD

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001865782
Company name	BrightSpring Health Services, Inc.
Country	United States
Country code	US
CUSIP number	10950A106
Earnings date	2026-10-30
Earnings time	bmo
Employees	23,500
Employees change	-13,500
Employees growth	-36.49%
Enterprise value	$14.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1974
In index	RUSSELL2000
Industry	Health Information Services
IPO date	2024-01-26
Is primary listing	Yes
Is SPAC	No
ISIN number	US10950A1060
Last 10-K release date	2026-02-27
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$12.4B
Market cap category	Large-Cap
Next earnings date	2026-10-30
Options	Yes
Price	$59.48
Price currency	USD
Sector	Healthcare
SIC code	8082
Stock price date	2026-10-28
Symbol	BTSG
U.S. state	Kentucky
Website	https://www.brightspringhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	2.75%
EV/Earnings	38.55x
EV/EBIT	30.28x
EV/EBITDA	22.51x
EV/FCF	35.07x
EV/Sales	0.98x
FCF / EV yield	2.85%
FCF yield	3.28%
Forward EV/Sales	0.86x
Forward P/E	28.81x
Forward P/S	0.75x
Graham number	19.14247
Graham upside	-67.51%
Industry forward P/E	34.7x
Lynch fair value	$40.95
Lynch upside	-30.49%
P/(FCF - SBC) ratio	35.81x
P/(OCF - SBC) ratio	27.47x
P/B ratio	5.87x
P/E ratio	36.31x
P/FCF ratio	30.5x
P/OCF ratio	24.24x
P/S ratio	0.85x
PEG ratio	0.61x
Price/EBITDA ratio	19.58x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.24%
EBITDA margin	4.36%
Effective tax rate	16.11%
FCF margin	2.8%
Gross margin	12.38%
Operating margin	3.24%
Pretax margin	2.06%
Profit margin	2.55%
Profit per employee	$15,573
Profitable quarters	7
Profitable years	1
Revenue per employee	$611,557
ROA	4.88%
ROA (5Y)	2.19%
ROCE	10.52%
ROE	13.04%
ROE (5Y)	-5.29%
ROIC	10.16%
ROIC (5Y)	3.93%
SBC / revenue	0.42%
Tax / revenue	0.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	399.96%
EPS growth (Q)	196.59%
EPS growth (QoQ)	-43.9%
EPS growth 5Y	43.42%
EPS growth quarters	9
EPS growth years	2
FCF growth	110.52%
FCF growth (QoQ)	-85.32%
FCF growth 5Y	9.24%
Gross profit growth	29.42%
Gross profit growth (Q)	31.45%
Gross profit growth 3Y	8.84%
Gross profit growth 5Y	9.54%
Net income growth	458.58%
Net income growth (Q)	198.82%
Net income growth (QoQ)	-43.34%
Net income growth 5Y	62.71%
Net income growth quarters	9
Net income growth years	2
OCF growth	88.56%
OCF growth (QoQ)	-64.28%
OCF growth 5Y	10.12%
Operating income growth	88.98%
Operating income growth (Q)	129.33%
Operating income growth 3Y	28.93%
Operating income growth 5Y	16.52%
Revenue growth	26.36%
Revenue growth (Q)	23.05%
Revenue growth (QoQ)	7.18%
Revenue growth 3Y	20.83%
Revenue growth 5Y	18.92%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-104M
Depreciation and amortization	$160.8M
EBIT	$466M
EBITDA	$626.8M
EPS	$1.64
FCF per share	$1.93
Financing cash flow	$-487.8M
Free cash flow	$402.4M
Free cash flow minus SBC	$342.7M
Gross profit	$1.8B
Income taxes	$47.6M
Investing cash flow	$461.6M
Net borrowing	$-359.7M
Net cash flow	$480.1M
Net income	$366M
Operating cash flow minus SBC	$446.7M
Operating income	$466M
Revenue	$14.4B
Stock-based compensation	$59.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.05
Book value per share	$9.94
Debt / EBITDA	3.42
Debt / equity	1.16
Debt / FCF	5.93
Goodwill	$2.5B
Interest coverage	3.06
Long-term assets	$3.5B
Long-term liabilities	$2.4B
Net cash (debt)	$-1.8B
Net cash / market cap	-14.97%
Net debt / EBITDA	2.93
Net debt / equity	0.89
Net debt / FCF	4.57
Piotroski F-Score	7
Property, plant and equipment	$380.8M
Shareholders' equity	$2.1B
Tangible book value	$-1B
Tangible book value per share	$-4.86
Total assets	$6B
Total cash	$550.4M
Total debt	$2.4B
Total liabilities	$3.9B
WACC	13.08%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	2.41
Current assets	$2.5B
Current liabilities	$1.6B
Current ratio	1.59
Inventory turnover	20.98
Net working capital	$457M
Quick ratio	1.2
Working capital	$914.3M
Working capital turnover	13.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.56%
Dividend yield	0%
Shareholder yield	-7.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$59.15
1D price change	1.91%
1M price change	5.1%
1M total return	5.1%
1W price change	-4.63%
1W total return	-4.63%
1Y price change	75.81%
1Y return CAGR	75.87%
1Y total return	75.81%
20-day SMA	$61.52
200-day SMA	$54.43
3M price change	-17.37%
3M total return	-17.37%
50-day SMA	$59.77
50-day SMA vs 200-day SMA	50over200
52-week high	$73.75
52-week high date	2026-07-27
52-week low	$30.64
52-week low date	2025-11-18
6M price change	22.45%
6M total return	22.45%
All-time high	$73.75
All-time high date	2026-07-27
All-time low	$7.85
All-time low date	2024-03-15
Average true range (ATR)	$1.85
Average volume	2M
Beta (1Y)	0.79
Beta (2Y)	1.17
Beta (5Y)	1.88
Change from 52-week high	-19.36%
Change from 52-week low	94.11%
Change from all-time high	-19.36%
Change from all-time low	657.64%
Change from open	1.48%
Day's gap	0.43%
Dollar volume	$91.4M
High price	$59.55
Low price	$58.56
Monthly RSI	71.85
Open price	$58.61
Position in 52-week range	92.42%
Premarket change	-0.62%
Premarket close	$58.36
Premarket price	$58.00
Premarket volume	263
Previous close	$58.36
Price vs 150-day SMA	0.55%
Price vs 20-day SMA	-3.33%
Price vs 200-day SMA	9.26%
Price vs 50-day SMA	-0.5%
Relative volume	0.77
Return from IPO open	390.92%
Return from IPO price	353.15%
RSI	45.61
Sharpe ratio	1.43
Sortino ratio	2.12
Volume	1.5M
Weekly RSI	53.45
YTD price change	58.81%
YTD total return	58.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	152.3M
Float percentage	73.12%
Shares change (QoQ)	-0.47%
Shares change (YoY)	7.56%
Shares held by insiders	1.1%
Shares held by institutions	93.16%
Shares outstanding	208.3M
Short % of float	7.87%
Short % of shares	5.75%
Short ratio	4.8 days

Deeper analysis on BTSG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BTSG report

Is a complete BTSG research report available?

No complete published report is available for BrightSpring Health Services, Inc. (BTSG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BrightSpring Health Services, Inc. (BTSG)

Price

Financial snapshot

Fair-value bridge

Latest news · BTSG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BTSG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BTSG

Frequently asked questions